News & Blog

Tag Archives: glioblastoma multiforme

Defeat GBM Research Collaborative Produces Important Discovery

As we wrote on this blog back in May, the issue of “acquired resistance” is one of the biggest challenges in successfully treating brain tumors. Acquired resistance refers to tumor cells’ ability to learn to dodge the effects of treatment. Once a tumor develops resistance, current drugs stop working and the tumor can resume growing. […]

Five Key Updates from the 2014 Scientific Meeting of the Society for Neuro-Oncology

The Society for Neuro-Oncology (SNO) Annual Scientific Meeting is a multi-day conference that serves as one of the most important gatherings in the field of brain tumor research and drug development. Over three days, presentations are given on some of the most promising research efforts in the field, as well as critical updates on many […]

Encouraging Results from Novocure Clinical Trial

Novocure, a company that creates medical devices to treat cancer, announced this weekend that their Novo-TTF-100A system (now being called Optune), in combination with temozolomide (also know as Temodar or TMZ), demonstrated improved survival in newly diagnosed glioblastoma multiforme (GBM) patients in a clinical trial, compared with temozolomide alone. The announcement was made at the […]

Share